Showing results (291-300 of 449) with videos related to
Sort By:
Pageof 45
Cell Stem Cell|July 6, 2013
The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformationSu Jung Song, Keisuke Ito, Ugo Ala, et al.Oncogene|January 23, 2004
Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalphaMahadeo A Sukhai, Xuemei Wu, Yali Xuan, et al.Nature Cell Biology|March 10, 2009
Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKBHui-Kuan Lin, Guocan Wang, Zhenbang Chen, et al.Nature Communications|October 9, 2015
LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repairXue-Song Liu, Gurushankar Chandramouly, Emilie Rass, et al.Cell Stem Cell|January 21, 2014
Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenanceLev M Kats, Markus Reschke, Riccardo Taulli, et al.Journal of Cellular and Molecular Medicine|July 13, 2026
Therapeutic Efficacy of Indole-3-Carbinol Against SARS-CoV-2-Induced Acute Respiratory Distress Syndrome: A Dual Antiviral and Anti-Inflammatory Approach in a Golden Syrian Hamster ModelCentofanti Federica, Rizzacasa Barbara, Latini Andrea, et al.Nature|November 18, 2008
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiencyMaria Barna, Aya Pusic, Ornella Zollo, et al.Cancer Research|May 16, 2015
Enhanced MET Translation and Signaling Sustains K-Ras-Driven Proliferation under Anchorage-Independent Growth ConditionsSaori Fujita-Sato, Jacqueline Galeas, Morgan Truitt, et al.Plos Biology|February 13, 2009
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2Morris E Feldman, Beth Apsel, Aino Uotila, et al.Bioinformatics (Oxford, England)|September 20, 2013
Assessing gene-level translational control from ribosome profilingAdam B Olshen, Andrew C Hsieh, Craig R Stumpf, et al.Pageof 45